TMCnet - World's Largest Communications and Technology Community


[December 17, 2012] Daily Watchlist: (OTCQB: BCLI), (OTCQB: GMEC), (OTCQB: AQLV), (OTCQB: ACTC)

Miami, FL, Dec 17, 2012 ( via COMTEX) Miami, FL - 12/17/2012 Penny Trackers is your # 1 trusted online source for the best penny stock news & information on today's best penny stock picks. Penny Trackers provides a FREE e-newsletter featuring some of the best picks in this fast moving industry. Stay informed! To receive our Free Penny Stock Newsletter visit ***These Penny Stocks are active this week :* ** Brainstorm Cell Therapeutics Inc. (OTCQB: BCLI)a development stage biotechnology company, engages in developing stem cell therapeutic products based on technologies enabling the in-vitro differentiation of bone marrow stem cells to neural-like cells. The company focuses to utilize the patient s own bone marrow stem cells to generate neurotrophic-factor (NTF) secreting cells that provide treatment for amyotrophic lateral sclerosis (ALS), Parkinson s disease, multiple sclerosis, and spinal cord injury. It holds rights to develop and commercialize the technology through a worldwide licensing agreement with Ramot, the technology transfer company of the Tel Aviv University; and has agreements with Hadasit Medical Research Services and Development Ltd. to conduct its ALS clinical trials at the Hadassah Medical Center. The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. Brainstorm Cell Therapeutics was founded in 2000 and is based in New York, New York.Get The Penny Trackers Free Penny Stock Newsletter Here: Great China Mania Holdings, Inc. (OTCQB: GMEC)through its subsidiaries, engages in the publication of electronic contents and magazines; provision of artist management services; and the retail sales of video games and accessories primarily in Hong Kong, Macau, and China. It offers event management and promotion services for its clients. The company publishes seven weekly or bi-weekly magazines that specialize in computer technologies, video games, digital equipment, and automobiles. It operates two retail stores to sell video game machines, as well as video games and accessories. The company was formerly known as Great East Bottles & Drinks (China) Holdings, Inc. and changed its name to Great China Mania Holdings, Inc. in March 2011. Great China Mania Holdings, Inc. is based in Hong Kong, Hong Kong.GetThe Penny Trackers Free Penny Stock Newsletter Here: Aqualiv Technologies, Inc. (OTCQB: AQLV)provides ingredient-free solutions worldwide. Its solutions include AquaLiv water systems that remove impurities, including sodium fluoride in water; Infotone Face Mist, a facial water mister; and AgSmart Rice, which increases rice crops yield and provides resistance to pests, disease, and storms. The company s product under development comprises NatuRx Medication Alternatives, a formulation that utilizes novel wave-based information composites in lieu of active-molecules for treatment. Its solutions are used for applications in water purification, environmental science, agriculture, animal husbandry, personal use products, and medicine industries. In addition, the company provides remote desktop and cloud computing solutions to small businesses; and Voice over Internet Protocol phone services to small businesses, as well as to households. The company was formerly known as Infrared Systems International and changed its name to AquaLiv Technologies, Inc. in September 2011. AquaLiv Technologies, Inc. is based in Silverdale, Washington.Get The Penny Trackers Free Penny Stock Newsletter Here: Advanced Cell Technology Inc. (OTCQB: ACTC)a biotechnology company, engages in the development and commercialization of human embryonic, induced pluripotency, and adult stem cell technology in the field of regenerative medicine. It has developed a range of intellectual property portfolio for specific applications of stem cell technology in producing retinal pigment epithelium cells, hemangioblasts, myoblast stem cells, and various methods and compositions for the use of these technologies and derived cells in treating retinal and other eye diseases, inflammatory and autoimmune diseases, and heart diseases, as well as to provide agents for wound healing and replacement of blood components. The company s human embryonic stem cell technologies comprise cellular reprogramming and pluripotent stem cell technologies to produce cells that have the proliferative capacity of embryonic stem cells with therapeutic application and compatible with the patient. Its cell therapy research programs include retinal pigment epithelium and hemangioblast programs; and stable cell lines with particular focus on blood lineage and vascular epithelial cell lines from hemangioblast cells. The company s adult stem cell program develops an autologous myoblast transplantation therapy to restore cardiac function in patients with advanced heart diseases. Advanced Cell Technology, Inc. develops and maintains an intellectual property portfolio, with ownership or licensing of approximately 35 issued patents and approximately 170 patent applications in the field of regenerative medicine and related areas. The company is headquartered in Marlborough, Massachusetts.Get The Penny Trackers Free Penny Stock Newsletter Here: Subscribe Here - Disclosure: http://www.PennyTrackers.comis not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit for complete risks and disclosures.

Contact: Penny Trackers / Associated Documentation:Link to submission on http://www.eteligis.comPennyTrackers_12-17-2012_SMU_4.docx

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy